[AIDS 2026] Managed Healthcare Executive: Community-led chemsex harm reduction programs boost HIV retention in South Africa, other countries

Back to the "HIV and Co-Infections News" list

Community-led programs across four countries show gains in HIV retention, mental health and service uptake among people who engage in chemsex.

Managed Healthcare Executive news story

Chemsex is the intentional use of psychoactive substances during sex to increase pleasure, decrease stress or prolong the sexual encounter. Examples include alkyl nitrites, colloquially referred to as “poppers,” methamphetamine and ketamine. Because chemsex can be associated with long sessions of unprotected sex and lowered inhibitions, it is associated with sharply elevated HIV risk, particularly for people who inject drugs. People who inject drugs face a risk of HIV acquisition roughly 14 times higher than the general adult population, and studies in Brazil have found chemsex prevalence among men who have sex with men ranging from 27% to almost 70%.

Despite this risk, structured, health-led responses to chemsex remain rare in much of the world, but outreach groups are trying to change that. Several of these groups presented their abstracts at AIDS 2026, during ‘Chemsex everywhere: Interventions across contexts.’ The session was led by Carolina Coutinho, Ph.D., a scientist and researcher at the National Institute of Infectious Diseases in Rio de Janeiro, Brazil.

Read the full news story here.


View all Managed Healthcare Executive reports from AIDS 2026


 

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.